Abstract:Background: Parkinson's disease (PD), the most common neurodegenerative disorder, primarily affects dopaminergic neurons in the substantia nigra (SN). In addition to severe motor dysfunction, PD patients appear apparent cognitive impairments in the late stage. Cognitive dysfunction is accompanied by synaptic transmission damage in the hippocampus. Cordycepin has been reported to alleviate cognitive impairments in neurodegenerative diseases. Purpose: The study aimed to estimate the protection roles of cordycepin on cognitive dysfunction in PD model and explore the potential mechanisms. Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was used to establish the PD model in vivo and in vitro experiments. In the in vivo experiments, the C57BL / 6 mice were intraperitoneally injected with MPTP and intragastric administration with cordycepin. Open field test (OFT) was used to estimate the exercise ability. Spontaneous alternation behavioral (SAB) and morris water maze (MWM) tests were used to evaluate the learning and memory abilities. The hippocampal slices from C57BL / 6 and Kunming mice in the in vitro experiments were used to record field excitatory postsynaptic potential (fEPSP) by electrophysiological methods. Western blotting was used to examine the level of tyrosine hydroxylase (TH) in the in vivo experiments and the levels of adenosine A(1) and A(2A) receptors (A(1)R and A(2A)R) in the in vitro experiments, respectively. The drugs of MPTP, cordycepin, DPCPX and SCH58261 were perfused through dissolving in artificial cerebrospinal fluid. Results: Cordycepin could significantly reduce the impairments on motor, exploration, spatial learning and memory induce by MPTP. MPTP reduced the amplitude of LTP in hippocampal CA1 area but cordycepin could improve LTP amplitudes. Cordycepin at dosage of 20 mg/kg also increased the TH level in SN. In the in vitro experiments, MPTP inhibited synaptic transmission in hippocampal Schaffer-CA1 pathway with a dose-dependent relationship, while cordycepin could reverse the inhibition of synaptic transmission. Furthermore, the roles of cordycepin on synaptic transmission could been attenuated in the presence of the antagonists of A(1)R and A(2A)R, DPCPX and SCH58261, respectively. Interestingly, the level of A(2A)R rather than A(1)R in hippocampus was significantly decreased in the cordycepin group as compared to the control. Conclusion: The present study has showed that cordycepin could improve cognitive function in the PD model induced by MPTP through regulating the adenosine A(2A) receptors. These findings were helpful to provide a new strategy for the dementia caused by Parkinson's disease.

Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission

Neuroprotective Effects of Natural Cordycepin on LPS-induced Parkinson’s Disease Through Suppressing TLR4/NF-κB/NLRP3-mediated Pyroptosis

Identification of Novel Proteins Affected by Rotenone in Mitochondria of Dopaminergic Cells

Neuroprotective Effects of Cordycepin on MPTP-induced Parkinson's Disease Mice Via Suppressing PI3K/AKT/mTOR and MAPK-mediated Neuroinflammation

Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-κB signaling pathway

Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease

Minocycline Protects Against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model

Effects of cordycepin on motor and cognition in Parkinson disease mice induced by MPTP

Rotenone Induction of Hydrogen Peroxide Inhibits Mtor-Mediated S6k1 and 4E-Bp1/eif4e Pathways, Leading to Neuronal Apoptosis

Protective effect of metformin against rotenone-induced parkinsonism in mice

3-N-butylphthalide Attenuates Neuroinflammation in Rotenone-Induced Parkinson's Disease Models Via the Cgas-Sting Pathway.

Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells

Icaritin Provides Neuroprotection in Parkinson's Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency

Rifampicin Attenuates Rotenone-Induced Inflammation Via Suppressing NLRP3 Inflammasome Activation in Microglia

Cordycepin Improved the Cognitive Function Through Regulating Adenosine A2A Receptors in MPTP Induced Parkinson's Disease Mice Model.

Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency

Geniposide protects against neurotoxicity in mouse models of rotenone-induced Parkinson's disease involving the mTOR and Nrf2 pathways

Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.

Neuroprotection of Cordycepin in NMDA-induced Excitotoxicity by Modulating Adenosine A(1) Receptors

Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson's disease induced by rotenone

3-N-butylphthalide attenuates neuroinflammation in rotenone-induced Parkinson’s disease models via the cGAS-STING pathway